
Biomarkers, Genetics, and Anti-Amyloid Therapies for Early Stages of AD
8/22/2025
0:00
26:06
Using biomarker testing and APOE genotyping to determine patient eligibility for amyloid-targeting therapies.
Credit available for this activity expires: 8/19/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002844?ecd=bdc_podcast_libsyn_mscpedu
More episodes from "Keeping Current CME"
Don't miss an episode of “Keeping Current CME” and subscribe to it in the GetPodcast app.